DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 3.31% to $6.13 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.19% to 27,190.86 and the Dow Jones Industrial Average rising 0.49% to 51,176.96.
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 70.18% short of its 52-week high of $20.56, which the company achieved on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 3.74% to $4.63, Fortress Biotech Inc. (FBIO) fell 1.93% to $2.03, and Viking Therapeutics Inc. (VKTX) fell 1.87% to $29.94.
Trading volume (834,833) eclipsed its 50-day average volume of 828,735.
Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.